Airway Inflammation

3

Review clinical trials related to Airway Inflammation. Use filters to narrow results by trial status, phase, treatment, biological sex and sponsor.

Condition / disease
Location
Status: Recruiting

Cost Effective Air Filtration Intervention in Low-Income Housing to Reduce Asthma Morbidity

This project will investigate the effectiveness of HEPA air cleaners in reducing indoor air pollution and improving asthma morbidity in children living in East Harlem, New York City (NYC). The study will be conducted over a 2-year period. Columbia University and Little Sisters of the Assumption Family Health Service (LSAFHS) will conduct an intervention study to evaluate the efficacy of using a cost-effective high-capacity high efficiency particulate air (HEPA) filter air cleaner to reduce airborne particulate matter (PM) in the homes of children with asthma and to reduce their asthma morbidity. The study will take place in East Harlem, a low-income neighborhood with high asthma prevalence. It will build on findings from prior Housing and Urban Development Lead and Healthy Homes Technical Studies (HUD LHHTS)-funded research, the experience of LSAFHS installing air cleaners in the homes of asthmatic children, and recent findings demonstrating the effectiveness of home air cleaners in reducing asthma morbidity. The investigators hypothesize that the cost-effective single air cleaner will substantially reduce PM exposure in the homes of asthmatic children and reduce airway inflammation and asthma morbidity. This study will use cutting-edge air sampling technology to continuously quantify and characterize indoor air pollutants in the home for one year, verify and incentivize compliance, and conduct repeated exhaled nitric oxide and pulmonary function tests before and throughout the year after the intervention. This cost-effective intervention can be easily and quickly implemented in homes in low-income, urban communities and easily transferred between homes if families move.

Participants needed: 55
Trial details
Age: 7-18Biological sex: AllType: InterventionalSponsor: Columbia UniversityUpdated: Jun 2, 2026Locations: 1
Eligibility criteria

Age 7-18 years [+2]

Inability to successfully perform spirometry maneuver or FeNO test [+1]

Status: Recruiting

Can Astaxanthin Help Manage Asthma in POlluted Areas?

This study will test whether astaxanthin, a naturally occurring antioxidant supplement, can improve lung function, reduce airway inflammation, and improve asthma control in adults with mild-to-moderate asthma. Participants will receive astaxanthin and placebo in random order in a double-blind crossover design. Each treatment period lasts 4 weeks and is separated by a 3-week washout period. The study also measures indoor and personal air pollution exposure to examine whether pollution influences asthma symptoms, airway responsiveness, and response to treatment. Exploratory thoracic bioelectrical impedance spectroscopy will be assessed alongside standard respiratory tests.

Participants needed: 25
Trial details
Age: 18+Biological sex: AllType: InterventionalSponsor: Middlesex UniversityUpdated: Apr 2, 2026Locations: 1
Eligibility criteria

Adults 18+ y [+10]

Current smokers or vapers which is associated with chronic airway remodelling, r... [+9]

Status: Recruiting

Immune Status and Disease Control of Inflammatory Airway Diseases

The goal of this study is to learn how the body's immune system affects disease control in people with different airway inflammatory diseases.We want to understand: 1.Whether specific immune cell patterns in the blood are linked to how severe the disease is or how well it is controlled. Participants will: 1. Answer questions about their health and symptoms. 2. Give blood samples 3. Have lung function tests and other standard check-ups. 4. share sleep study results. We will compare people with airway diseases to healthy volunteers to see how their immune systems differ.

Participants needed: 200
Trial details
Age: 18+Biological sex: AllType: ObservationalSponsor: First Affiliated Hospital of Ningbo UniversityUpdated: Mar 25, 2026Locations: 1
Eligibility criteria

Age ≥18 years (≥40 years for COPD patients). [+4]

Patients with severe respiratory diseases other than those included in the study... [+5]